Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia.

Read PJ, Limnios EA, McNulty A, Whiley D, Lahra MM.

Sex Health. 2013 Nov;10(5):460-2. doi: 10.1071/SH13077.


Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008.

WHO Western Pacific Programme; South East Asian Gonococcal Antimicrobial Surveillance Programme, Tapsall JW, Limnios EA, Abu Bakar HM, Darussalam B, Ping YY, Buadromo EM, Kumar P, Singh S, Lo J, Bala M, Risbud A, Deguchi T, Tanaka M, Watanabe Y, Lee K, Chong Y, Noikaseumsy S, Phouthavane T, Sam IC, Tundev O, Lwin KM, Eh PH, Goarant C, Goursaud R, Bathgate T, Brokenshire M, Latorre L, Velemu E, Carlos C, Leano S, Telan EO, Goh SS, Koh ST, Ngan C, Tan AL, Mananwatte S, Piyanoot N, Lokpichat S, Sirivongranson P, Fakahau M, Sitanilei H, Hung le V.

Commun Dis Intell Q Rep. 2010 Mar;34(1):1-7.


Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2.

Whiley DM, Goire N, Lambert SB, Ray S, Limnios EA, Nissen MD, Sloots TP, Tapsall JW.

J Antimicrob Chemother. 2010 Aug;65(8):1615-8. doi: 10.1093/jac/dkq187. Epub 2010 May 28.


Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.

Tapsall JW, Limnios EA, Murphy D; Australian Gonococcal Surveillance Programme.

J Antimicrob Chemother. 2008 Jan;61(1):150-5. Epub 2007 Nov 6.


Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone.

Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW.

Antimicrob Agents Chemother. 2007 Sep;51(9):3111-6. Epub 2007 Jun 25.


Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004 - implications for treatment.

Sutrisna A, Soebjakto O, Wignall FS, Kaul S, Limnios EA, Ray S, Nguyen NL, Tapsall JW.

Int J STD AIDS. 2006 Dec;17(12):810-2.


Further questions regarding the role of mosaic penA sequences in conferring reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae.

Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW.

Antimicrob Agents Chemother. 2007 Feb;51(2):802-3. Epub 2006 Nov 13. No abstract available.


Evidence that the gonococcal porA pseudogene is present in a broad range of Neisseria gonorrhoeae strains; suitability as a diagnostic target.

Whiley DM, Anderson TP, Barratt K, Beaman MH, Buda PJ, Carter M, Freeman K, Hallsworth P, Limnios EA, Lum G, Merien F, Vernel-Pauillac F, Tapsall JW, Witt MJ, Nissen MD, Sloots TP.

Pathology. 2006 Oct;38(5):445-8.


A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR.

Lum G, Freeman K, Nguyen NL, Limnios EA, Tabrizi SN, Carter I, Chambers IW, Whiley DM, Sloots TP, Garland SM, Tapsall JW.

Sex Transm Infect. 2005 Oct;81(5):400-2.


Cryptic-plasmid-free gonococci may contribute to failure of cppB gene-based assays to confirm results of BD ProbeTEC PCR for identification of Neisseria gonorrhoeae.

Tapsall JW, Limnios EA, Nguyen NL, Carter I, Lum G, Freeman K, Tabrizi SN, Garland SM, Whiley DM, Sloots TP, Chambers IW.

J Clin Microbiol. 2005 Apr;43(4):2036-7. No abstract available.


The antibiotic susceptibility of Neisseria gonorrhoeae isolated in Ulaanbaatar, Mongolia.

Lkhamsuren E, Shultz TR, Limnios EA, Tapsall JW.

Sex Transm Infect. 2001 Jun;77(3):218-9. No abstract available.


Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters.

Tapsall JW, Shultz TR, Limnios EA, Donovan B, Lum G, Mulhall BP.

Sex Transm Dis. 1998 Nov;25(10):505-8.


High-level quinolone resistance in Neisseria gonorrhoeae: a report of two cases.

Tapsall JW, Limnios EA, Thacker C, Donovan B, Lynch SD, Kirby LJ, Wise KA, Carmody CJ.

Sex Transm Dis. 1995 Sep-Oct;22(5):310-1.


Supplemental Content

Loading ...
Support Center